Skip to main content

GENOMICA MEDICA DE LA IMMUNODEFICIENCIA COMUN VARIABLE (IDCV)

SAF2012-35025

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Nacional de Proyectos de Investigación Fundamental
Subprogram Subprograma de Proyectos de Investigación Fundamental no Orientada
Call Proyectos I+D
Call year 2012
State Plan 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Management unit Secretaría de Estado de Investigación, Desarrollo e Innovación
Beneficiary centre UNIVERSITAT POMPEU FABRA CCT

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Evaluating the genetics of common variable immunodeficiency: monogenetic model and beyond

  • Valles Ibáñez, Guillem de, 1986-
  • Hernández Rodríguez, Jéssica, 1983-
  • Laayouni, Hafid, 1968-
  • Cuscó Martí, Ivon, 1973-
  • Codina i Solà, Marta, 1988-
  • Batlle Masó, Laura, 1993-
  • Solís Moruno, Manuel, 1993-
  • Marquès i Bonet, Tomàs, 1975-
  • Bosch Fusté, Elena
  • Casals López, Ferran
Common variable immunodeficiency (CVID) is the most frequent symptomatic primary immunodeficiency characterized by recurrent infections, hypogammaglobulinemia and poor response to vaccines. Its diagnosis is made based on clinical and immunological criteria, after exclusion of other diseases that can cause similar phenotypes. Currently, less than 20% of cases of CVID have a known underlying genetic cause. We have analyzed whole-exome sequencing and copy number variants data of 36 children and adolescents diagnosed with CVID and healthy relatives to estimate the proportion of monogenic cases. We have replicated an association of CVID to p.C104R in TNFRSF13B and reported the second case of homozygous patient to date. Our results also identify five causative genetic variants in LRBA, CTLA4, NFKB1, and PIK3R1, as well as other very likely causative variants in PRKCD, MAPK8, or DOCK8 among others. We experimentally validate the effect of the LRBA stop-gain mutation which abolishes protein production and downregulates the expression of CTLA4, and of the frameshift indel in CTLA4 producing expression downregulation of the protein. Our results indicate a monogenic origin of at least 15-24% of the CVID cases included in the study. The proportion of monogenic patients seems to be lower in CVID than in other PID that have also been analyzed by whole exome or targeted gene panels sequencing. Regardless of the exact proportion of CVID monogenic cases, other genetic models have to be considered for CVID. We propose that because of its prevalence and other features as intermediate penetrancies and phenotypic variation within families, CVID could fit with other more complex genetic scenarios. In particular, in this work, we explore the possibility of CVID being originated by an oligogenic model with the presence of heterozygous mutations in interacting proteins or by the accumulation of detrimental variants in particular immunological pathways, as well as perform association tests to detect association with rare genetic functional variation in the CVID cohort compared to healthy controls., This study was funded by grants SAF2012-35025 and SAF2015-68472-C2-2-R from the Ministerio de Economía y Competitividad (Spain) and FEDER (EU) to FC; by Direcció General de Recerca, Generalitat de Catalunya (2014SGR-866 and 2017SGR-702) to FC and EB; to EB by grant BFU2016-77961-P from Ministerio de Economía, Industria y Competitividad (Spain) AEI (Spain) and FEDER (EU); by Instituto de Salud Carlos III, grant PI14/00405, cofinanced by the European Regional Development Fund (ERDF) to RC; partially funded by CERCA Programme/Generalitat de Catalunya (JIA), and SAF2015-68472-C2-1-R grant from the Spanish Ministry of Economy and Competitiveness co-financed by European Regional Development Fund (ERDF) to JIA; GV-I was supported by grant BES-2012-051794; JH-R was supported by grant BES-2013-064333. TMB is supported by U01 MH106874 grant, Howard Hughes International Early Career, Obra Social “La Caixa” and Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya. All phases of this study were supported by the projects PI12/01990 and PI15/01094 to LA and PI13/00676 to MJ. This work was also supported by the Jeffrey Modell Foundation. This study makes use of data generated by the Medical Genome Project. A full list of the investigators who contributed to the generation of the data is available from http://www.medicalgenomeproject.com/en. Funding for the project was provided by the Spanish Ministry of Economy and Competitiveness, projects I + D + i 2008, Subprograma de actuaciones Científicas y Tecnológicas en Parques Científicos y Tecnológicos (ACTEPARQ 2009) and ERFD.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Genetic diagnosis of autoinflammatory disease patients using clinical exome sequencing

  • Batlle Masó, Laura, 1993-
  • Mensa Vilaró, Anna
  • Solís Moruno, Manuel, 1993-
  • Marquès i Bonet, Tomàs, 1975-
  • Aróstegui Gorospe, Juan Ignacio
  • Casals López, Ferran
Autoinflammatory diseases comprise a wide range of syndromes caused by dysregulation of the innate immune response. They are difficult to diagnose due to their phenotypic heterogeneity and variable expressivity. Thus, the genetic origin of the disease remains undetermined for an important proportion of patients. We aim to identify causal genetic variants in patients with suspected autoinflammatory disease and to test the advantages and limitations of the clinical exome gene panels for molecular diagnosis. Twenty-two unrelated patients with clinical features of autoinflammatory diseases were analyzed using clinical exome sequencing (~4800 genes), followed by bioinformatic analyses to detect likely pathogenic variants. By integrating genetic and clinical information, we found a likely causative heterozygous genetic variant in NFKBIA (p.D31N) in a North-African patient with a clinical picture resembling the deficiency of interleukin-1 receptor antagonist, and a heterozygous variant in DNASE2 (p.G322D) in a Spanish patient with a suspected lupus-like monogenic disorder. We also found variants likely to increase the susceptibility to autoinflammatory diseases in three additional Spanish patients: one with an initial diagnosis of juvenile idiopathic arthritis who carries two heterozygous UNC13D variants (p.R727Q and p.A59T), and two with early-onset inflammatory bowel disease harbouring NOD2 variants (p.L221R and p.A728V respectively). Our results show a similar proportion of molecular diagnosis to other studies using whole exome or targeted resequencing in primary immunodeficiencies. Thus, despite its main limitation of not including all candidate genes, clinical exome targeted sequencing can be an appropriate approach to detect likely causative variants in autoinflammatory diseases., This study was funded by grants SAF2012-35025 and SAF2015-68472-C2-2-R from the Ministerio de Economía y Competitividad (Spain) and FEDER (EU) to FC; RTI2018-096824-B-C22 grant from the Spanish Ministry of Science, Innovation and Universities co-financed by ERDF (FC), by Direcció General de Recerca, Generalitat de Catalunya (2014SGR-866 and 2017SGR-702) to FC, the CERCA Programme, Generalitat de Catalunya (JIA), SAF2015-68472-C2-1-R grant from the Spanish Ministry of Economy and Competitiveness co-financed by European Regional Development Fund (ERDF) (JIA), RTI2018-096824-B-C21 grant from the Spanish Ministry of Science, Innovation and Universities co-financed by ERDF (JIA), and AC15/00027 grant from the Instituto de Salud Carlos III, Transnational Research Projects on Rare Diseases (JIA). LBM is supported by a Formació de personal Investigador fellowship from Generalitat de Catalunya (2018_FI_B00072). MSM is supported by the María de Maetzu Programme (MDM-2014-0370-16-3).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The impact of endogenous content, replicates and pooling on genome capture from faecal samples

  • Hernández Rodríguez, Jéssica, 1983-
  • Arandjelovic, Mimi
  • Lester, Jack
  • Filippo, Cesare de
  • Weihmann, Antje
  • Meyer, Matthias
  • Angedakin, Samuel
  • Casals López, Ferran
  • Navarro i Cuartiellas, Arcadi, 1969-
  • Vigilant, Linda
  • Kühl, Hjalmar S.
  • Langergraber, Kevin
  • Boesch, Christophe
  • Hughes, David
  • Marquès i Bonet, Tomàs, 1975-
Target-capture approach has improved over the past years, proving to be very efficient tool for selectively sequencing genetic regions of interest. These methods have also allowed the use of noninvasive samples such as faeces (characterized by their low quantity and quality of endogenous DNA) to be used in conservation genomic, evolution and population genetic studies. Here we aim to test different protocols and strategies for exome capture using the Roche SeqCap EZ Developer kit (57.5 Mb). First, we captured a complex pool of DNA libraries. Second, we assessed the influence of using more than one faecal sample, extract and/or library from the same individual, to evaluate its effect on the molecular complexity of the experiment. We validated our experiments with 18 chimpanzee faecal samples collected from two field sites as a part of the Pan African Programme: The Cultured Chimpanzee. Those two field sites are in Kibale National Park, Uganda (N = 9) and Loango National Park, Gabon (N = 9). We demonstrate that at least 16 libraries can be pooled, target enriched through hybridization, and sequenced allowing for the genotyping of 951,949 exome markers for population genetic analyses. Further, we observe that molecule richness, and thus, data acquisition, increase when using multiple libraries from the same extract or multiple extracts from the same sample. Finally, repeated captures significantly decrease the proportion of off-target reads from 34.15% after one capture round to 7.83% after two capture rounds, supporting our conclusion that two rounds of target enrichment are advisable when using complex faecal samples., JH-R is supported by the Ministerio de Economía y Competitividad, Spain (FPI grant BES-2013-064333). This work was supported by the Ministerio de Economía y Competitividad, Spain, and Fondo Europeo de Desarollo Regional (FEDER) (SAF2012-35025 and SAF2015-68472-C2-2-R to FC). The collection of faecal samples was supported by the Max Planck Society Innovation Fund and the Heinz L. Krekeler Foundation's generous funding for the Pan African Programme: The Cultured Chimpanzee. We thank the Agence Nationale des Parcs Nationaux and the Centre National de la Recherche Scientifique (CENAREST) in Gabon and the Uganda National Council for Science and Technology (UNCST) and Ugandan Wildlife Authority (UWA) for their support and permission to collect and export samples from their respective nations. AN is funded by MINECO BFU2015-68649-P (FEDER). TM-B is supported by MINECO BFU2014-55090-P (FEDER), U01 MH106874 grant, Howard Hughes International Early Career, Fundació Zoo de Barcelona and Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Evaluating the genetics of common variable immunodeficiency: monogenetic model and beyond

  • Valles Ibáñez, Guillem de, 1986-
  • Hernández Rodríguez, Jéssica, 1983-
  • Laayouni, Hafid, 1968-
  • Cuscó Martí, Ivon, 1973-
  • Codina i Solà, Marta, 1988-
  • Batlle Masó, Laura, 1993-
  • Solís Moruno, Manuel, 1993-
  • Marquès i Bonet, Tomàs, 1975-
  • Bosch Fusté, Elena
  • Casals López, Ferran
Common variable immunodeficiency (CVID) is the most frequent symptomatic primary immunodeficiency characterized by recurrent infections, hypogammaglobulinemia and poor response to vaccines. Its diagnosis is made based on clinical and immunological criteria, after exclusion of other diseases that can cause similar phenotypes. Currently, less than 20% of cases of CVID have a known underlying genetic cause. We have analyzed whole-exome sequencing and copy number variants data of 36 children and adolescents diagnosed with CVID and healthy relatives to estimate the proportion of monogenic cases. We have replicated an association of CVID to p.C104R in TNFRSF13B and reported the second case of homozygous patient to date. Our results also identify five causative genetic variants in LRBA, CTLA4, NFKB1, and PIK3R1, as well as other very likely causative variants in PRKCD, MAPK8, or DOCK8 among others. We experimentally validate the effect of the LRBA stop-gain mutation which abolishes protein production and downregulates the expression of CTLA4, and of the frameshift indel in CTLA4 producing expression downregulation of the protein. Our results indicate a monogenic origin of at least 15-24% of the CVID cases included in the study. The proportion of monogenic patients seems to be lower in CVID than in other PID that have also been analyzed by whole exome or targeted gene panels sequencing. Regardless of the exact proportion of CVID monogenic cases, other genetic models have to be considered for CVID. We propose that because of its prevalence and other features as intermediate penetrancies and phenotypic variation within families, CVID could fit with other more complex genetic scenarios. In particular, in this work, we explore the possibility of CVID being originated by an oligogenic model with the presence of heterozygous mutations in interacting proteins or by the accumulation of detrimental variants in particular immunological pathways, as well as perform association tests to detect association with rare genetic functional variation in the CVID cohort compared to healthy controls., This study was funded by grants SAF2012-35025 and SAF2015-68472-C2-2-R from the Ministerio de Economía y Competitividad (Spain) and FEDER (EU) to FC; by Direcció General de Recerca, Generalitat de Catalunya (2014SGR-866 and 2017SGR-702) to FC and EB; to EB by grant BFU2016-77961-P from Ministerio de Economía, Industria y Competitividad (Spain) AEI (Spain) and FEDER (EU); by Instituto de Salud Carlos III, grant PI14/00405, cofinanced by the European Regional Development Fund (ERDF) to RC; partially funded by CERCA Programme/Generalitat de Catalunya (JIA), and SAF2015-68472-C2-1-R grant from the Spanish Ministry of Economy and Competitiveness co-financed by European Regional Development Fund (ERDF) to JIA; GV-I was supported by grant BES-2012-051794; JH-R was supported by grant BES-2013-064333. TMB is supported by U01 MH106874 grant, Howard Hughes International Early Career, Obra Social “La Caixa” and Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya. All phases of this study were supported by the projects PI12/01990 and PI15/01094 to LA and PI13/00676 to MJ. This work was also supported by the Jeffrey Modell Foundation. This study makes use of data generated by the Medical Genome Project. A full list of the investigators who contributed to the generation of the data is available from http://www.medicalgenomeproject.com/en. Funding for the project was provided by the Spanish Ministry of Economy and Competitiveness, projects I + D + i 2008, Subprograma de actuaciones Científicas y Tecnológicas en Parques Científicos y Tecnológicos (ACTEPARQ 2009) and ERFD.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The impact of endogenous content, replicates and pooling on genome capture from faecal samples

  • Hernández Rodríguez, Jéssica, 1983-
  • Arandjelovic, Mimi
  • Lester, Jack
  • Filippo, Cesare de
  • Weihmann, Antje
  • Meyer, Matthias
  • Angedakin, Samuel
  • Casals López, Ferran
  • Navarro i Cuartiellas, Arcadi, 1969-
  • Vigilant, Linda
  • Kühl, Hjalmar S.
  • Langergraber, Kevin
  • Boesch, Christophe
  • Hughes, David
  • Marquès i Bonet, Tomàs, 1975-
Target-capture approach has improved over the past years, proving to be very efficient tool for selectively sequencing genetic regions of interest. These methods have also allowed the use of noninvasive samples such as faeces (characterized by their low quantity and quality of endogenous DNA) to be used in conservation genomic, evolution and population genetic studies. Here we aim to test different protocols and strategies for exome capture using the Roche SeqCap EZ Developer kit (57.5 Mb). First, we captured a complex pool of DNA libraries. Second, we assessed the influence of using more than one faecal sample, extract and/or library from the same individual, to evaluate its effect on the molecular complexity of the experiment. We validated our experiments with 18 chimpanzee faecal samples collected from two field sites as a part of the Pan African Programme: The Cultured Chimpanzee. Those two field sites are in Kibale National Park, Uganda (N = 9) and Loango National Park, Gabon (N = 9). We demonstrate that at least 16 libraries can be pooled, target enriched through hybridization, and sequenced allowing for the genotyping of 951,949 exome markers for population genetic analyses. Further, we observe that molecule richness, and thus, data acquisition, increase when using multiple libraries from the same extract or multiple extracts from the same sample. Finally, repeated captures significantly decrease the proportion of off-target reads from 34.15% after one capture round to 7.83% after two capture rounds, supporting our conclusion that two rounds of target enrichment are advisable when using complex faecal samples., JH-R is supported by the Ministerio de Economía y Competitividad, Spain (FPI grant BES-2013-064333). This work was supported by the Ministerio de Economía y Competitividad, Spain, and Fondo Europeo de Desarollo Regional (FEDER) (SAF2012-35025 and SAF2015-68472-C2-2-R to FC). The collection of faecal samples was supported by the Max Planck Society Innovation Fund and the Heinz L. Krekeler Foundation's generous funding for the Pan African Programme: The Cultured Chimpanzee. We thank the Agence Nationale des Parcs Nationaux and the Centre National de la Recherche Scientifique (CENAREST) in Gabon and the Uganda National Council for Science and Technology (UNCST) and Ugandan Wildlife Authority (UWA) for their support and permission to collect and export samples from their respective nations. AN is funded by MINECO BFU2015-68649-P (FEDER). TM-B is supported by MINECO BFU2014-55090-P (FEDER), U01 MH106874 grant, Howard Hughes International Early Career, Fundació Zoo de Barcelona and Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Genetic diagnosis of autoinflammatory disease patients using clinical exome sequencing

  • Batlle Masó, Laura, 1993-
  • Mensa Vilaró, Anna
  • Solís Moruno, Manuel, 1993-
  • Marquès i Bonet, Tomàs, 1975-
  • Aróstegui Gorospe, Juan Ignacio
  • Casals López, Ferran
Autoinflammatory diseases comprise a wide range of syndromes caused by dysregulation of the innate immune response. They are difficult to diagnose due to their phenotypic heterogeneity and variable expressivity. Thus, the genetic origin of the disease remains undetermined for an important proportion of patients. We aim to identify causal genetic variants in patients with suspected autoinflammatory disease and to test the advantages and limitations of the clinical exome gene panels for molecular diagnosis. Twenty-two unrelated patients with clinical features of autoinflammatory diseases were analyzed using clinical exome sequencing (~4800 genes), followed by bioinformatic analyses to detect likely pathogenic variants. By integrating genetic and clinical information, we found a likely causative heterozygous genetic variant in NFKBIA (p.D31N) in a North-African patient with a clinical picture resembling the deficiency of interleukin-1 receptor antagonist, and a heterozygous variant in DNASE2 (p.G322D) in a Spanish patient with a suspected lupus-like monogenic disorder. We also found variants likely to increase the susceptibility to autoinflammatory diseases in three additional Spanish patients: one with an initial diagnosis of juvenile idiopathic arthritis who carries two heterozygous UNC13D variants (p.R727Q and p.A59T), and two with early-onset inflammatory bowel disease harbouring NOD2 variants (p.L221R and p.A728V respectively). Our results show a similar proportion of molecular diagnosis to other studies using whole exome or targeted resequencing in primary immunodeficiencies. Thus, despite its main limitation of not including all candidate genes, clinical exome targeted sequencing can be an appropriate approach to detect likely causative variants in autoinflammatory diseases., This study was funded by grants SAF2012-35025 and SAF2015-68472-C2-2-R from the Ministerio de Economía y Competitividad (Spain) and FEDER (EU) to FC; RTI2018-096824-B-C22 grant from the Spanish Ministry of Science, Innovation and Universities co-financed by ERDF (FC), by Direcció General de Recerca, Generalitat de Catalunya (2014SGR-866 and 2017SGR-702) to FC, the CERCA Programme, Generalitat de Catalunya (JIA), SAF2015-68472-C2-1-R grant from the Spanish Ministry of Economy and Competitiveness co-financed by European Regional Development Fund (ERDF) (JIA), RTI2018-096824-B-C21 grant from the Spanish Ministry of Science, Innovation and Universities co-financed by ERDF (JIA), and AC15/00027 grant from the Instituto de Salud Carlos III, Transnational Research Projects on Rare Diseases (JIA). LBM is supported by a Formació de personal Investigador fellowship from Generalitat de Catalunya (2018_FI_B00072). MSM is supported by the María de Maetzu Programme (MDM-2014-0370-16-3).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Detection of genomic rearrangements from targeted resequencing data in Parkinson's disease patients

  • Spataro, Nino|||0000-0002-2127-2238
  • Roca-Umbert, Ana
  • Cervera Carles, Laura|||0000-0003-2286-200X
  • Vallès, Mònica
  • Anglada, Roger
  • Pagonabarraga Mora, Javier|||0000-0002-3248-704X
  • Pascual Sedano, Berta María|||0000-0002-9298-8241
  • Campolongo, Antonia|||0000-0002-7962-3264
  • Kulisevsky, Jaime|||0000-0003-4870-1431
  • Casals, Ferran|||0000-0002-8941-0369
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Bosch, Elena|||0000-0003-2848-103X
The analysis of coverage depth in next-generation sequencing data allows the detection of gene dose alterations. We explore the frequency of such structural events in a Spanish cohort of sporadic PD cases. Gene dose alterations were detected with the eXome-Hidden Markov Model (XHMM) software from depth of coverage in resequencing data available for 38 Mendelian and other risk PD loci in 394 individuals (249 cases and 145 controls) and subsequently validated by quantitative PCR. We identified 10 PD patients with exon dosage alterations in PARK2, GBA-GBAP1, and DJ1. Additional functional variants, including 2 novel nonsense mutations (p.Arg1552Ter in LRRK2 and p.Trp90Ter in PINK1), were confirmed by Sanger sequencing. This combined approach disclosed the genetic cause of 12 PD cases. Gene dose alterations related to PD can be correctly identified from targeting resequencing data. This approach substantially improves the detection rate of cases with causal genetic alterations. © 2016 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Evaluating the Genetics of Common Variable Immunodeficiency, Monogenetic Model and Beyond

  • de Valles-Ibáñez, Guillem
  • Esteve-Sole, Ana|||0000-0002-0542-0587
  • Piquer, Mònica
  • González-Navarro, Europa Azucena|||0000-0003-3310-5557
  • Hernandez-Rodriguez, Jessica|||0000-0002-0402-286X
  • Laayouni, Hafid|||0000-0003-1297-5078
  • González Roca, Eva|||0000-0002-1126-0321
  • Plaza-Martin, Ana María
  • Deyà-Martínez, Ángela|||0000-0002-8026-7674
  • Martín Nalda, Andrea|||0000-0002-1715-153X
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
  • Garcia-Prat, Marina|||0000-0001-5387-1908
  • Del Pino Molina, Lucía|||0000-0003-2392-097X
  • Cusco, Ivon|||0000-0003-2104-9332
  • Codina Solà, Marta|||0000-0002-5382-413X
  • Batlle-Masó, Laura|||0000-0002-4209-176X
  • Solís-Moruno, Manuel|||0000-0001-7407-8896
  • Marquès i Bonet, Tomàs|||0000-0002-5597-3075
  • Bosch, Elena|||0000-0003-2848-103X
  • López Granados, Eduardo
  • Aróstegui, Juan Ignacio|||0000-0003-4757-504X
  • Soler Palacín, Pere|||0000-0002-0346-5570
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
  • Yagüe, Jordi|||0000-0001-8210-1929
  • Alsina Manrique, Laia|||0000-0002-3559-0018
  • Juan, Manel|||0000-0002-3064-1648
  • Casals, Ferran|||0000-0002-8941-0369
Common variable immunodeficiency (CVID) is the most frequent symptomatic primary immunodeficiency characterized by recurrent infections, hypogammaglobulinemia and poor response to vaccines. Its diagnosis is made based on clinical and immunological criteria, after exclusion of other diseases that can cause similar phenotypes. Currently, less than 20% of cases of CVID have a known underlying genetic cause. We have analyzed whole-exome sequencing and copy number variants data of 36 children and adolescents diagnosed with CVID and healthy relatives to estimate the proportion of monogenic cases. We have replicated an association of CVID to p.C104R in TNFRSF13B and reported the second case of homozygous patient to date. Our results also identify five causative genetic variants in LRBA, CTLA4, NFKB1, and PIK3R1, as well as other very likely causative variants in PRKCD, MAPK8, or DOCK8 among others. We experimentally validate the effect of the LRBA stop-gain mutation which abolishes protein production and downregulates the expression of CTLA4, and of the frameshift indel in CTLA4 producing expression downregulation of the protein. Our results indicate a monogenic origin of at least 15-24% of the CVID cases included in the study. The proportion of monogenic patients seems to be lower in CVID than in other PID that have also been analyzed by whole exome or targeted gene panels sequencing. Regardless of the exact proportion of CVID monogenic cases, other genetic models have to be considered for CVID. We propose that because of its prevalence and other features as intermediate penetrancies and phenotypic variation within families, CVID could fit with other more complex genetic scenarios. In particular, in this work, we explore the possibility of CVID being originated by an oligogenic model with the presence of heterozygous mutations in interacting proteins or by the accumulation of detrimental variants in particular immunological pathways, as well as perform association tests to detect association with rare genetic functional variation in the CVID cohort compared to healthy controls.